## Relevance-ranked evidence overview

The records contain a small number of papers directly addressing protein-function prediction, alongside a larger group concerning protein structure prediction, protein–protein interactions, drug discovery, or clinical prediction. The latter topics are relevant only indirectly. Because the supplied records provide titles and bibliographic metadata but not study details, datasets, or results, specific claims about performance require full-text verification.

### Tier 1: Directly relevant to protein-function prediction

| Rank | Record | Likely contribution based on title | Dataset and metric information | Verification status |
|---|---|---|---|---|
| 1 | **Structure-based protein function prediction using graph convolutional networks** (Gligorijević et al., 2021; DOI: 10.1038/s41467-021-23303-9) | Most directly relevant primary study. It appears to use graph convolutional networks to infer protein function from structural representations, probably through residue-, domain-, or protein-level structural graphs. | Not available from the record. The full text should be checked for structural sources, GO terms, train/test splitting, and metrics such as Fmax, AUPR, AUROC, or precision/recall. | **Full-text verification essential. A local PDF is listed.** |
| 2 | **Novel machine learning approaches revolutionize protein knowledge** (Bordin et al., 2023; PMID: 36504138) | Broad review of machine learning applications in protein science. It is likely to discuss protein language models, representation learning, annotation, structure, and function prediction. | Dataset and metric coverage cannot be determined from the title. | **Full-text verification required.** |
| 3 | **Machine Learning Approaches for Metalloproteins** (Yu et al., 2022; PMID: 35209064) | Review focused on machine learning for metalloproteins. It may cover prediction of metal-binding sites, metalloprotein classes, catalytic properties, or related functions. | The relevant datasets and evaluation criteria are unknown. The scope may include structural and biochemical prediction rather than general protein-function annotation. | **Full-text verification required.** |
| 4 | **Exploring the Power of Machine Learning in Analysing Protein-Protein Sequences** (Nag et al., 2026; PMID: 42018649) | Potentially relevant to sequence-based protein analysis and function or interaction prediction, but the title is broad and does not establish that function prediction is a central endpoint. | Unknown. | **Full-text verification required; relevance should first be confirmed.** |

### Tier 2: Closely related methods that may support function prediction

| Record | Relevance to the question | What it can contribute |
|---|---|---|
| **AI-Driven Deep Learning Techniques in Protein Structure Prediction** (Chen et al., 2024) | Indirect | Reviews deep-learning methods for predicting structure. Predicted structures can provide features for downstream functional annotation, but structure prediction is not itself function prediction. |
| **Highly accurate protein structure prediction with AlphaFold** (Jumper et al., 2021) | Indirect but foundational | Establishes a major structure-prediction framework. It is relevant because structural representations are increasingly used for function inference. The paper’s primary evaluation concerns structure accuracy rather than functional annotation. |
| **AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences** (Varadi et al., 2023) | Indirect, important resource | Provides a large source of predicted structures that can be used as input to structure-based function-prediction models. It should not be treated as evidence that the database itself predicts protein function. |
| **Accurate structure prediction of biomolecular interactions with AlphaFold 3** (Abramson et al., 2024) | Indirect | Extends structural prediction to complexes and interactions. Potentially useful for predicting interaction-mediated functions, but not a direct function-prediction study. |
| **Hierarchical graph learning for protein-protein interaction** (Gao et al., 2023) | Adjacent | Relevant to interaction prediction. Interaction partners can provide functional evidence, but PPI prediction and protein-function prediction are distinct tasks. |
| **Machine Learning Methods in Protein-Protein Docking** (Michalik and Kuder, 2024) | Adjacent | Concerns prediction of binding or docking configurations rather than protein function. May inform structural interaction modelling. |
| **Rapid directed evolution guided by protein language models and epistatic interactions** (Tran et al., 2026) | Adjacent | Uses protein language models to guide sequence optimisation. Language-model representations may also be used for function prediction, but this record appears focused on directed evolution. |
| **Sequence-based virtual screening using transformers** (Zhang et al., 2025) | Adjacent | Applies transformer models to sequence-based ligand or target screening. It may predict biochemical activity, but this is narrower than general protein-function annotation. |
| **Robust deep learning–based protein sequence design using ProteinMPNN** (Dauparas et al., 2022) | Adjacent but not directly relevant | Protein design rather than function prediction. |
| **AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges** (Schauperl and Denny, 2022) | Indirect review | Useful for discussing structure-derived features and limitations, but not a direct source on function-prediction benchmarks. |
| **Computational modelling of olfactory receptors** (Odoemelam et al., 2025) | Narrowly adjacent | May address receptor structure or ligand interactions. The title does not establish a machine-learning protein-function prediction task. |

### Tier 3: Methodological background

These records may help interpret model design, evaluation, or limitations but do not provide direct evidence on protein-function prediction:

- **A guide to machine learning for biologists** (Greener et al., 2021): general guidance on model construction, validation, and interpretation.
- **Review of deep learning: concepts, CNN architectures, challenges, applications, future directions** (Alzubaidi et al., 2021): general deep-learning background.
- **Leakage and the reproducibility crisis in machine-learning-based science** (Kapoor and Narayanan, 2023): highly relevant to assessing data leakage, non-independent test sets, and reproducibility in protein benchmarks.
- **Informed Machine Learning** (von Rueden et al., 2021): relevant to incorporating biological prior knowledge into models.
- **Practical guide to SHAP analysis** (Ponce Bobadilla et al., 2024): potentially relevant to model interpretability, although not protein-specific.
- **Ensemble deep learning: A review** (Ganaie et al., 2022): general ensemble methodology.
- **Small data machine learning in materials science** (Xu et al., 2023): potentially informative for small labelled biological datasets, but not protein-specific.
- **Generative AI** (Feuerriegel et al., 2023): broad methodological context only.

### Tier 4: Not relevant to the stated question

The following records concern clinical prediction, disease mechanisms, treatment response, drug discovery, or unrelated applications. They should generally be excluded from a focused review of machine learning for protein-function prediction:

- Machine learning-based prediction of type 2 diabetes subtypes.
- AKT and EZH2 inhibitors in triple-negative breast cancer.
- LCN2 and renal transplantation injury.
- Discovery of a natural RORγt inhibitor.
- Baicalein in cervical cancer.
- Prediction of mortality in HBV-related acute-on-chronic liver failure.
- AI-guided therapy discovery in inflammatory bowel disease.
- Drug efficacy prediction in lung cancer.
- Multi-omics prediction of diabetic retinopathy and treatment response.
- mTOR/p53 co-targeting therapy in AML.
- Swarm learning for decentralized clinical machine learning.
- Multi-omics machine-learning review.
- Machine learning in agriculture.
- Diabetes prediction using fused machine learning.
- Other general clinical or application-oriented records in the supplied list.

These papers may use proteins as biomarkers or targets, but that is not equivalent to predicting the molecular function of a protein.

## How machine learning is being used

The directly and closely related records suggest three main modelling strategies:

1. **Sequence-based prediction**
   - Protein sequences can be represented using amino-acid composition, k-mer or evolutionary profiles, recurrent or convolutional networks, transformers, or protein language models.
   - The likely prediction targets include functional labels, enzyme classes, binding properties, protein–protein interactions, or biochemical activities.
   - Protein language models are particularly relevant because they learn contextual representations from large unlabelled sequence collections and can be fine-tuned using smaller labelled datasets.

2. **Structure-based prediction**
   - A protein can be represented as a graph in which residues or atoms are nodes and spatial proximity, chemical contacts, or covalent bonds are edges.
   - Graph convolutional or geometric neural networks can then predict functional annotations from three-dimensional structure.
   - AlphaFold-derived structures substantially increase the number of proteins for which structural features can be generated, although predicted structures are not equivalent to experimentally determined functional states.

3. **Interaction- and network-based prediction**
   - Protein–protein interaction graphs, docking models, and hierarchical graph representations can provide contextual evidence for function.
   - These approaches may infer function from interaction partners or molecular complexes, but their performance depends strongly on the quality and completeness of interaction data.

## Datasets that should be identified and verified

The supplied metadata do not specify datasets. Full-text review should determine whether the studies use:

- **UniProt/Swiss-Prot** or related curated protein annotations.
- **Gene Ontology (GO)** annotations for molecular function, biological process, and cellular component.
- **CAFA** benchmark datasets and evaluation protocols.
- **Protein Data Bank (PDB)** structures.
- **AlphaFold Protein Structure Database** predictions.
- **Pfam, InterPro, PROSITE, CATH, or SCOP** domain and family annotations.
- Enzyme classification resources such as **EC numbers**.
- Protein–protein interaction resources such as **STRING, BioGRID, IntAct, or DIP**.
- Metal-binding or metalloprotein-specific curated datasets.

Important dataset properties to verify include the annotation date, sequence-identity threshold used to remove homologues, treatment of proteins with multiple labels, class imbalance, species composition, and whether test proteins are evolutionarily distant from the training set.

## Evaluation metrics

For protein-function prediction, the most informative metrics are usually multi-label and ontology-aware:

- **Precision, recall, and F1 score**
- **AUPR**, particularly for highly imbalanced functional labels
- **AUROC**, although it can appear optimistic under severe class imbalance
- **Fmax**, commonly used in GO-function prediction
- **Smin**, which incorporates semantic distance between predicted and true GO terms
- **Coverage**, label-ranking metrics, or per-class performance
- Performance stratified by sequence identity, protein family, or annotation depth

Metrics used for structure prediction—such as RMSD, TM-score, or lDDT—should not be presented as evidence of function-prediction accuracy. Similarly, docking scores, binding-affinity error, or interaction-prediction AUPR measure related but different tasks.

## Remaining limitations

Several limitations are likely to be central:

1. **Incomplete and biased annotations**  
   Protein databases contain many uncharacterised proteins, unevenly distributed annotations, and literature-derived biases. Absence of an annotation does not necessarily mean absence of a function.

2. **Homology and data leakage**  
   Random sequence-level splits can place highly similar proteins in both training and test sets, producing inflated performance. The leakage and reproducibility record is especially relevant here. Clustered, family-level, temporal, or taxonomically separated test sets are more informative.

3. **Class imbalance and ontology structure**  
   Common GO terms are easier to predict than rare terms. Predictions are also hierarchically dependent: a model may correctly predict a broad parent term while missing the specific child function.

4. **Limited out-of-distribution generalisation**  
   Models may perform well on proteins resembling the training data but poorly on new taxa, remote homologues, unusual domains, membrane proteins, disordered proteins, or multifunctional proteins.

5. **Dependence on input quality**  
   Structure-based methods are affected by uncertain or incorrect predicted structures, missing ligands, conformational flexibility, and the fact that protein function often depends on complexes, post-translational modifications, cellular localisation, and environmental conditions.

6. **Prediction is not experimental validation**  
   A high benchmark score does not establish biochemical activity. Experimental testing remains necessary, particularly for novel proteins and low-confidence predictions.

7. **Interpretability and biological plausibility**  
   Neural models may identify predictive sequence or structural features without providing a mechanistic explanation. Interpretability tools such as SHAP can help, but explanations should not automatically be treated as causal evidence.

## Overall assessment

The strongest evidence in this set is the structure-based graph-convolutional study and the reviews focused on machine learning in protein science and metalloproteins. The records support a broad picture in which protein-function prediction is increasingly based on learned sequence representations, predicted or experimental structures, and interaction networks. However, the supplied metadata do not permit reliable conclusions about which datasets or metrics were actually used, nor about comparative performance. Those details should be extracted from the full texts, with particular attention to homology-aware data splitting, independent evaluation, rare-function performance, and experimental validation.